Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA408437
Max Phase: Preclinical
Molecular Formula: C116H147N29O28
Molecular Weight: 2395.63
Molecule Type: Protein
Associated Items:
ID: ALA408437
Max Phase: Preclinical
Molecular Formula: C116H147N29O28
Molecular Weight: 2395.63
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H]1CC(=O)NCC(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2c[nH]cn2)C(=O)NCC(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N2CCC[C@@H]2C(=O)N1)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
Standard InChI: InChI=1S/C116H147N29O28/c1-10-59(6)97(113(169)141-88(116(172)173)42-67-50-123-76-28-19-16-25-73(67)76)144-112(168)96(58(4)5)143-110(166)87(47-95(153)154)139-101(157)77(34-35-90(117)148)131-107(163)84(44-69-52-120-56-127-69)132-99(155)60(7)128-102(158)79(38-63-21-12-11-13-22-63)134-104(160)80(39-64-30-32-70(147)33-31-64)135-103(159)78(37-57(2)3)133-105(161)81(40-65-48-121-74-26-17-14-23-71(65)74)137-109(165)86-46-92(150)124-53-93(151)130-85(45-91(118)149)108(164)136-82(41-66-49-122-75-27-18-15-24-72(66)75)106(162)138-83(43-68-51-119-55-126-68)100(156)125-54-94(152)142-98(62(9)146)114(170)129-61(8)115(171)145-36-20-29-89(145)111(167)140-86/h11-19,21-28,30-33,48-52,55-62,77-89,96-98,121-123,146-147H,10,20,29,34-47,53-54H2,1-9H3,(H2,117,148)(H2,118,149)(H,119,126)(H,120,127)(H,124,150)(H,125,156)(H,128,158)(H,129,170)(H,130,151)(H,131,163)(H,132,155)(H,133,161)(H,134,160)(H,135,159)(H,136,164)(H,137,165)(H,138,162)(H,139,157)(H,140,167)(H,141,169)(H,142,152)(H,143,166)(H,144,168)(H,153,154)(H,172,173)/t59-,60-,61-,62+,77-,78-,79-,80-,81-,82-,83+,84-,85+,86+,87-,88-,89+,96-,97-,98+/m0/s1
Standard InChI Key: HVXXWNYSHBMHER-YBNDZOOFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 2395.63 | Molecular Weight (Monoisotopic): 2394.0970 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Suzawa T, Shibata K, Tanaka T, Matsuda Y, Yamasaki M. (1997) RES-701-1/endothelin-1 hybrid peptide having a potent binding activity for type B receptor, 7 (13): [10.1016/S0960-894X(97)00296-5] |
Source(1):